These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22592436)

  • 1. Minimal-change nephropathy in systemic lupus erythematosus.
    Redondo-Pachón MD; Enríquez R; Sirvent AE; Andrada E; Millán I; Amorós F
    Nefrologia; 2012 May; 32(3):412-3. PubMed ID: 22592436
    [No Abstract]   [Full Text] [Related]  

  • 2. A case of minimal change disease complicated by acute kidney injury in systemic lupus erythematosus.
    Wong KW
    Saudi J Kidney Dis Transpl; 2014 Nov; 25(6):1308-11. PubMed ID: 25394457
    [No Abstract]   [Full Text] [Related]  

  • 3. A case of minimal change disease treated successfully with mycophenolate mofetil in a patient with systemic lupus erythematosus.
    Hong YH; Yun DY; Jung YW; Oh MJ; Kim HJ; Lee CK
    Korean J Intern Med; 2011 Dec; 26(4):470-3. PubMed ID: 22205851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute kidney injury associated with minimal change disease in systemic lupus erythematosus: a case report.
    Wei X; Wang Y; Tu L; Wan H; Chen Q
    J Med Case Rep; 2014 Dec; 8():422. PubMed ID: 25495593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rituximab-responsive nephrotic syndrome due to minimal change disease in systemic lupus erythematosus.
    Shahane A; Khasnis A; Gota C
    J Clin Rheumatol; 2012 Jun; 18(4):199-202. PubMed ID: 22647855
    [No Abstract]   [Full Text] [Related]  

  • 6. [A case of minimal change nephrotic syndrome manifesting acute renal failure in the course of systemic lupus erythematosus].
    Sugimoto T; Yamasaki Y; Kobayashi M; Usui H; Matsuda M; Ohishi T; Ichikawa H; Nakamura Y; Nagake Y; Makino H
    Nihon Jinzo Gakkai Shi; 2002; 44(5):476-82. PubMed ID: 12216481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Immunosuppressive treatment of patients with a nephrotic syndrome due to minimal change glomerulopathy].
    Branten AJ; Wetzels JF
    Ned Tijdschr Geneeskd; 1998 Dec; 142(52):2832-8. PubMed ID: 10065257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimal change nephrotic syndrome associated with systemic lupus erythematosus.
    Horino T; Takao T; Morita T; Ito H; Hashimoto K
    Nephrol Dial Transplant; 2006 Jan; 21(1):230. PubMed ID: 16221690
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of Adult Minimal Change Disease.
    Korbet SM; Whittier WL
    Clin J Am Soc Nephrol; 2019 Jun; 14(6):911-913. PubMed ID: 30952629
    [No Abstract]   [Full Text] [Related]  

  • 10. Minimal-change nephrotic syndrome associated with systemic lupus erythematosus.
    Makino H; Haramoto T; Shikata K; Ogura T; Ota Z
    Am J Nephrol; 1995; 15(5):439-41. PubMed ID: 7503146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emerging minimal-change nephrotic syndrome in a patient with chronic mesangial proliferative lupus nephritis.
    Deji N; Sugimoto T; Kanasaki M; Aoyama M; Tanaka Y; Sakaguchi M; Nishio Y; Uzu T; Kashiwagi A
    Intern Med; 2007; 46(13):991-5. PubMed ID: 17603239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Woman with type 1 diabetes mellitus and rapidly progressive edema].
    Ehren M; Dietrich JW
    Dtsch Med Wochenschr; 2013 May; 138(18):940-4. PubMed ID: 23613372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cyclophosphamide-induced lupus flare in diffuse proliferative lupus nephropathy].
    Heras M; Saiz A; Fernández-Reyes MJ; Sánchez R; Zurita P; Urrego C
    Nefrologia; 2011; 31(2):231-3. PubMed ID: 21461001
    [No Abstract]   [Full Text] [Related]  

  • 14. Nephrotic syndrome and ARF in a diabetic patient.
    Stokes MB; Kwakye J; D'Agati VD
    Am J Kidney Dis; 2003 Jun; 41(6):1327-33. PubMed ID: 12776287
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunosupressive or anti-inflammatory?
    Br Med J; 1967 Mar; 1(5541):650-1. PubMed ID: 6019660
    [No Abstract]   [Full Text] [Related]  

  • 16. Nephrotic syndrome in mesangial proliferative lupus nephritis.
    Watanabe T
    Pediatr Int; 2007 Dec; 49(6):1009-11. PubMed ID: 18045314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corticosteroid-sparing strategies in the treatment of retinal vasculitis in systemic lupus erythematosus.
    Neumann R; Foster CS
    Retina; 1995; 15(3):201-12. PubMed ID: 7569347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic lupus erythematosus in a patient with remitting minimal change nephrotic syndrome.
    Nishihara G; Nakamoto M; Yasunaga C; Takeda K; Matsuo K; Urabe M; Goya T; Sakemi T
    Clin Nephrol; 1997 Nov; 48(5):327-30. PubMed ID: 9403219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Minimal change disease in systemic lupus erythematosus.
    Dube GK; Markowitz GS; Radhakrishnan J; Appel GB; D'Agati VD
    Clin Nephrol; 2002 Feb; 57(2):120-6. PubMed ID: 11863121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nephrotic syndrome: minimal change disease.
    Aziz F; Qureshi AM
    J Ayub Med Coll Abbottabad; 2001; 13(4):35-40. PubMed ID: 11873430
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.